Wegovy (semaglutide) is a GLP-1 receptor agonist that reduces appetite, slows digestion, and helps regulate blood sugar
If this occurs, We will likely increase your dose so you can continue to see results in your weight loss journey
Protein took the lead as the top nutrient in 2025, with an explosion of product innovation offering protein-rich food and beverage options
World Health Organisation data shows that 43% of over-18s are overweight, and 16% are obese
When injection site reactions significantly impact treatment adherence, discussing alternative GLP-1 options with healthcare providers represents a reasonable approach, as therapeutic efficacy across the class often allows successful substitution while maintaining glycemic control or weight management benefits
If a service cannot tell you who your prescriber is, what happens if you have a reaction, or how your records will be shared, those are the questions to ask before the first shipment rather than after
